HAVCR2 and osteosarcoma: In the same study, HAVCR2 was found to have a prognostic role in CESC, KIRC, SKCM, and osteosarcoma, and an adverse role in the prognosis of GBM, GBMLGG, LGG, PRAD, and UVM.